Deutsche Bank’s Genetic Technologies Ltd. GENE Stock Holding History

Deutsche Bank’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,014	Closed	-$64K	–	4728
2021 Q2	$64K	Hold	3,014	–	–	﹤0.01%	4256
2021 Q1	$63K	Hold	3,014	–	–	﹤0.01%	4178
2020 Q4	$54K	Hold	3,014	–	–	﹤0.01%	4103
2020 Q3	$52K	Hold	3,014	–	–	﹤0.01%	3878
2020 Q2	$34K	Buy	+3,014	New	+$30.7K	﹤0.01%	3961
2020 Q1	–	Sell	-200	Closed	-$1K	–	4941
2019 Q4	$1K	Buy	+200	New	+$1.95K	﹤0.01%	4944
2017 Q3	–	Sell	-30	Closed	–	–	5138
2017 Q2	$0	Buy	+30	New	+$628	﹤0.01%	5169
2016 Q4	–	Sell	-20	Closed	–	–	5111
2016 Q3	$0	Sell	20 -2	-9%	-$81	﹤0.01%	5257
2016 Q2	$0	Sell	22 -130	-86%	-$5.99K	﹤0.01%	5382
2016 Q1	$7K	Buy	+152	New	+$6.62K	﹤0.01%	4907
2015 Q4	–	Sell	-390	Closed	-$13K	–	5449
2015 Q3	$13K	Buy	+390	New	+$20.9K	﹤0.01%	4898

Other funds holding GENE

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Deutsche Bank's GENE Position: Q3 2021 in Review

Deutsche Bank sold out of Genetic Technologies Ltd. (GENE) in Q3 2021, closing a stake of 3,014 shares — an estimated $64K sold.

Deutsche Bank first reported a position in GENE in Q3 2015 and held it in 11 quarters. The position peaked at $64K in Q2 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q3 2021.

Deutsche Bank reported no remaining Genetic Technologies Ltd. position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 3,014 Genetic Technologies Ltd. shares in Q3 2021, an estimated $64K.
Deutsche Bank first reported a position in Genetic Technologies Ltd. in Q3 2015 and held it in 11 quarters.
Deutsche Bank's Genetic Technologies Ltd. position peaked at $64K in Q2 2021.
12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.